Knowledge

Template:Pharmacomodulation

Source 📝

723: 816: 824: 812: 831: 37: 491: 644: 588: 297: 847: 738: 481: 30: 852: 663: 577: 649: 471: 125: 119: 638: 410: 553: 326: 392: 231: 218: 189: 134: 688: 205: 582: 528: 513: 485: 266: 261: 252: 683: 654: 622: 452: 257: 213: 164: 95: 564: 370: 695: 539: 272: 159: 700: 544: 397: 350: 8: 321: 109: 752: 548: 517: 248: 144: 617: 522: 345: 138: 607: 401: 316: 70: 742: 535: 447: 285: 280: 150: 114: 104: 87: 227: 82: 65: 841: 463: 362: 354: 337: 276: 717: 442: 308: 291: 46: 599: 572: 505: 198: 78: 780:
will show the template collapsed, i.e. hidden apart from its title bar.
745:), it is hidden apart from its title bar; if not, it is fully visible. 425: 240: 434: 384: 15: 737:, meaning that if there is another collapsible item on the page (a 475: 99: 612: 181: 61: 804:
will show the template expanded, i.e. fully visible.
809:Editors can experiment in this template's sandbox 748:To change this template's initial visibility, the 839: 31: 720: 38: 24: 732:initial visibility currently defaults to 239: 840: 45: 19: 743:table with the collapsible attribute 13: 645:Angiotensin II receptor antagonist 589:Endocannabinoid reuptake inhibitor 14: 864: 536:Acetylcholine receptor antagonist 298:Norepinephrine reuptake inhibitor 721: 664:Vasopressin receptor antagonist 578:Cannabinoid receptor antagonist 650:Endothelin receptor antagonist 514:Acetylcholine receptor agonist 273:Adrenergic receptor antagonist 1: 482:Glutamate receptor antagonist 398:Serotonin receptor antagonist 351:Histamine receptor antagonist 126:Negative allosteric modulator 120:Positive allosteric modulator 639:Adenosine reuptake inhibitor 573:Cannabinoid receptor agonist 492:Glutamate reuptake inhibitor 411:Serotonin reuptake inhibitor 322:Dopamine receptor antagonist 7: 327:Dopamine reuptake inhibitor 249:Adrenergic receptor agonist 10: 869: 808: 618:Opioid receptor antagonist 472:Glutamate receptor agonist 393:Serotonin receptor agonist 346:Histamine receptor agonist 832:Subpages of this template 783: 759: 676: 631: 598: 563: 504: 462: 433: 424: 383: 336: 317:Dopamine receptor agonist 307: 226: 212: 197: 180: 173: 53: 583:Endocannabinoid enhancer 529:Cholinesterase inhibitor 448:GABA receptor antagonist 848:Drug navigational boxes 623:Enkephalinase inhibitor 613:Opioid receptor agonist 453:GABA reuptake inhibitor 158:♦ Miscellaneous: 853:Pharmacology templates 726:Template documentation 206:Ion channel modulators 443:GABA receptor agonist 659:receptor antagonist 788:Pharmacomodulation 764:Pharmacomodulation 47:Pharmacomodulation 715: 714: 711: 710: 672: 671: 500: 499: 420: 419: 190:Enzyme inhibition 860: 828: 820: 803: 802: 798: 795: 792: 789: 786: 779: 778: 774: 771: 768: 765: 762: 751: 750:|state= 735: 730:This template's 727: 725: 724: 689:Enzyme cofactors 608:Opioid modulator 565:Cannabinoidergic 431: 430: 237: 236: 224: 223: 178: 177: 40: 33: 26: 17: 16: 868: 867: 863: 862: 861: 859: 858: 857: 838: 837: 836: 835: 830: 822: 810: 807: 800: 796: 793: 790: 787: 784: 776: 772: 769: 766: 763: 760: 749: 739:navbox, sidebar 733: 728: 722: 716: 707: 668: 658: 627: 594: 559: 496: 458: 416: 405: 379: 374: 366: 358: 332: 303: 217: 208: 193: 169: 115:Inverse agonist 105:Partial agonist 49: 44: 12: 11: 5: 866: 856: 855: 850: 821:and testcases 806: 805: 781: 719: 718: 713: 712: 709: 708: 706: 705: 693: 680: 678: 674: 673: 670: 669: 667: 666: 661: 656: 652: 647: 642: 635: 633: 629: 628: 626: 625: 620: 615: 610: 604: 602: 596: 595: 593: 592: 586: 580: 575: 569: 567: 561: 560: 558: 557: 551: 542: 533: 532: 531: 520: 510: 508: 502: 501: 498: 497: 495: 494: 489: 479: 468: 466: 460: 459: 457: 456: 450: 445: 439: 437: 428: 422: 421: 418: 417: 415: 414: 408: 403: 395: 389: 387: 381: 380: 378: 377: 372: 368: 364: 360: 356: 348: 342: 340: 334: 333: 331: 330: 324: 319: 313: 311: 305: 304: 302: 301: 295: 289: 283: 270: 264: 255: 245: 243: 234: 221: 210: 209: 203: 201: 195: 194: 186: 184: 175: 171: 170: 168: 167: 162: 155: 154: 148: 142: 130: 129: 123: 117: 112: 107: 102: 91: 90: 85: 74: 73: 68: 57: 55: 51: 50: 43: 42: 35: 28: 20: 9: 6: 4: 3: 2: 865: 854: 851: 849: 846: 845: 843: 833: 826: 818: 814: 782: 758: 757: 756: 755:may be used: 754: 746: 744: 740: 736: 703: 702: 697: 694: 691: 690: 685: 682: 681: 679: 677:Miscellaneous 675: 665: 662: 660: 653: 651: 648: 646: 643: 640: 637: 636: 634: 630: 624: 621: 619: 616: 614: 611: 609: 606: 605: 603: 601: 597: 590: 587: 584: 581: 579: 576: 574: 571: 570: 568: 566: 562: 555: 552: 550: 546: 543: 541: 537: 534: 530: 527: 526: 524: 521: 519: 515: 512: 511: 509: 507: 503: 493: 490: 487: 483: 480: 477: 473: 470: 469: 467: 465: 464:Glutamatergic 461: 454: 451: 449: 446: 444: 441: 440: 438: 436: 432: 429: 427: 423: 412: 409: 406: 399: 396: 394: 391: 390: 388: 386: 382: 375: 369: 367: 361: 359: 352: 349: 347: 344: 343: 341: 339: 338:Histaminergic 335: 328: 325: 323: 320: 318: 315: 314: 312: 310: 306: 299: 296: 293: 290: 287: 284: 282: 278: 274: 271: 268: 265: 263: 259: 256: 254: 250: 247: 246: 244: 242: 238: 235: 233: 229: 225: 222: 220: 215: 211: 207: 202: 200: 196: 192: 191: 185: 183: 179: 176: 172: 166: 163: 161: 157: 156: 152: 149: 146: 143: 140: 136: 132: 131: 127: 124: 121: 118: 116: 113: 111: 108: 106: 103: 101: 97: 93: 92: 89: 86: 84: 80: 76: 75: 72: 69: 67: 63: 59: 58: 56: 52: 48: 41: 36: 34: 29: 27: 22: 21: 18: 747: 734:autocollapse 731: 729: 699: 687: 385:Serotonergic 309:Dopaminergic 188: 23: 701:Amino acids 600:Opioidergic 506:Cholinergic 219:transporter 199:Ion channel 135:Transporter 79:Ion channel 842:Categories 549:Ganglionic 540:Muscarinic 518:Muscarinic 241:Adrenergic 110:Antagonist 775:collapsed 753:parameter 696:Precursor 545:Nicotinic 523:Nicotinic 435:GABAergic 160:Precursor 145:Inhibitor 71:Inhibitor 799:expanded 684:Cofactor 554:Muscular 214:Receptor 165:Cofactor 151:Releaser 139:Enhancer 133:♦ 96:Receptor 94:♦ 77:♦ 60:♦ 815:| 641:(AdoRI) 591:(eCBRI) 174:Classes 100:Agonist 88:Blocker 66:Inducer 829:pages. 825:create 817:mirror 813:create 585:(eCBE) 182:Enzyme 83:Opener 62:Enzyme 794:state 770:state 741:, or 698:(see 686:(see 632:Other 455:(GRI) 413:(SRI) 329:(DRI) 300:(NRI) 216:& 128:(NAM) 122:(PAM) 54:Types 486:NMDA 476:AMPA 402:5-HT 204:See 187:see 153:(RA) 147:(RI) 141:(RE) 844:: 801:}} 785:{{ 777:}} 761:{{ 655:NK 556:)) 525:) 426:AA 269:)) 228:BA 137:: 98:: 81:: 64:: 834:. 827:) 823:( 819:) 811:( 797:= 791:| 773:= 767:| 704:) 692:) 657:1 547:( 538:( 516:( 488:) 484:( 478:) 474:( 407:) 404:3 400:( 376:) 373:3 371:H 365:2 363:H 357:1 355:H 353:( 294:) 292:β 288:) 286:2 281:1 279:( 277:α 275:( 267:2 262:1 260:( 258:β 253:α 251:( 232:M 230:/ 39:e 32:t 25:v

Index

v
t
e
Pharmacomodulation
Enzyme
Inducer
Inhibitor
Ion channel
Opener
Blocker
Receptor
Agonist
Partial agonist
Antagonist
Inverse agonist
Positive allosteric modulator
Negative allosteric modulator
Transporter
Enhancer
Inhibitor
Releaser
Precursor
Cofactor
Enzyme
Enzyme inhibition
Ion channel
Ion channel modulators
Receptor
transporter
BA

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.